Different factors have contributed to the lack of racial diversity in ophthalmology residency programs, and these programs build the future of the workforce, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.
Different factors have contributed to the lack of racial diversity in ophthalmology residency programs, and these programs build the future of the workforce, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.
Transcript
You recently found that ophthalmology residency programs are the least racially diverse programs in the United States. Why do you think that is and what impact is that having on care?
We know that having a racially diverse physician workforce that reflects patient population, or our census, can decrease health care disparities. It can improve access to care among minorities, it can improve overall patient outcomes and satisfaction. However, various studies have shown that ophthalmology is not a racially diverse specialty. And the composition of the ophthalmology workforce certainly does not reflect the status of our society and census.
We know that residency and training build the future of this workforce. Therefore, we wanted to look at their racial and ethnic composition of residency programs. I’m using data from the Accreditation Council for Graduate Medical Education, or ACGME, and found that in [the] 2019-2020 academic year, only 6% of ophthalmology residents belong to the groups that are underrepresented in medicine. This is far lower than other surgical or nonsurgical specialties.
Different factors can contribute to these disparities. Many medical schools do not have a home ophthalmology program. Also, medical students are exposed to ophthalmology towards the end of their medical training in medical school, and this does not give them enough time to build interest in ophthalmology. Moreover, a diverse mentorship in medical school is important in encouraging students to pursue ophthalmology, which is not existent in a lot of the medical schools.
So, in the past recent years, efforts have been made to improve the situation. The Minority Ophthalmology Mentoring Program by the American Academy of Ophthalmology and Association of University Professors of Ophthalmology, AUPO, is one of these programs. Through this program, interested minority students are paired with faculty mentors to introduce them to the field of ophthalmology early on, and to make them more competitive for residency application. More research needs to be done in the next coming years to evaluate the effect of these newer programs in composition of residency programs in the years to come.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
CMS Medicare Final Rule: Advancing Benefits, Competition, and Consumer Protection
May 7th 2024On this episode of Managed Care Cast, we're talking with Karen Iapoce, senior director of government products and programs at ZeOmega, about the recent CMS final rule on Medicare Part D and Medicare Advantage.
Listen
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More